Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
B8300 ML38522 CitationSummary: NRF2 inhibitor -
B8304 N1,N11-Diethylnorspermine tetrahydrochloride -
B8314 Chlorin e61 CitationSummary: A photosensitizer with antibacterial efficacy and anticancer activity -
B8317 ZerumboneSummary: Zerumbone -
A8783 VU661013Summary: Novel, potent, selective MCL-1 inhibitor -
B8319 FX1Summary: A small-molecule inhibitor that selectively inhibits BCL6-mediated signaling pathways -
B8320 HDM201Summary: A potent, selective inhibitor of the p53-Mdm2 interaction -
B8353 CCF642 -
B8387 ErdafitinibSummary: An orally available pan-FGFR inhibitor with potential antitumor activity -
B8396 RAD51 Inhibitor B021 CitationSummary: An inhibitor that suppresses human RAD51 activity and enhances the antitumor effect of cisplatin


